Skip to content

WHWK WHWK Current ratio

Current ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.5×+0.1×
Pfizer logo
PfizerPFE
1.2×0.0×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
3.6×-1.4×
Gilead Sciences logo
Gilead SciencesGILD
+0.6×
AbbVie logo
AbbVieABBV
0.8×0.0×
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
10.7×-3.2×

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×

Where this comes from

Calculated from WHWK’s reported figures.

Based on the most recent quarter.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's current ratio?
WHWK (WHWK) reported current ratio of 11.4× in Q1 2026.
How has WHWK's current ratio changed year-over-year?
WHWK's current ratio decreased by 40.1% year-over-year, from 19× to 11.4×.
What is the long-term trend for WHWK's current ratio?
Over 4 years (2021 to 2025), WHWK's current ratio has grown at a 0.9% compound annual growth rate (CAGR), from 9.9× to 10.3×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.